Karyopharm Therapeutics
KPTI
KPTI
77 hedge funds and large institutions have $187M invested in Karyopharm Therapeutics in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-8
Holders Change %
-9.41%
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
8
Increased
17
Reduced
33
Closed
16
Calls
$803K
Puts
$221K
Net Calls
+$582K
Net Calls Change
+$108K
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$9.78M |
| 2 |
JPMorgan Chase & Co
New York
|
+$562K |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$382K |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$221K |
| 5 |
State Street
Boston,
Massachusetts
|
+$177K |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$7.89M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$2.02M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1.06M |
| 4 |
D.E. Shaw & Co
New York
|
-$632K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$630K |
